Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does AI-Driven Technostress Promote or Hinder Employees' Artificial Intelligence Adoption Intention? A Moderated Mediation Model of Affective Reactions and Technical Self-Efficacy.

Psychology research and behavior management·2024
Same author

Clustering by chemicals: A novel examination of chemical pollutants and social vulnerability in children and adolescents.

Environmental research·2024
Same author

Regulation of Follicular Development in Chickens: <i>WIF1</i> Modulates Granulosa Cell Proliferation and Progesterone Synthesis via Wnt/β-Catenin Signaling Pathway.

International journal of molecular sciences·2024
Same author

Green potassium fertilizer from enzymatic hydrolysis lignin: Effects of lignin fractionation on wheat seed germination and seedling growth.

International journal of biological macromolecules·2024
Same author

Hawthorn total flavonoids ameliorate ambient fine particulate matter-induced insulin resistance and metabolic abnormalities of lipids in mice.

Ecotoxicology and environmental safety·2024
Same author

Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification.

Pathology, research and practice·2024
Same journal

RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. <i>Cells</i> 2022, <i>11</i>, 1502.

Cells·2026
Same journal

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026
Same journal

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.

Cells·2026
Same journal

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Cells·2026
Same journal

Activity of DNA- and RNA-Guided Prokaryotic Argonautes in Human Mitochondria.

Cells·2026
Same journal

Placental Pathophysiology in Maternal Psychoactive Substance Use: Biological, Clinical, and Forensic Perspectives.

Cells·2026
See all related articles

Related Experiment Video

Updated: Oct 30, 2025

Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.4K

Chamber-Specific Protein Expression during Direct Cardiac Reprogramming.

Zhentao Zhang1,2,3, Jesse Villalpando1,2,3, Wenhui Zhang1,2,3

  • 1Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Cells
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Cardiac reprogramming converts fibroblasts into cardiomyocyte-like cells (iCMs). In vivo reprogramming after heart attack specifically creates ventricular cells, unlike in vitro methods, suggesting a promising regenerative strategy.

Keywords:
cardiomyocytechamberfibroblastreprogramming

More Related Videos

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.6K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

8.9K

Related Experiment Videos

Last Updated: Oct 30, 2025

Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.4K
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.6K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

8.9K

Area of Science:

  • Cardiovascular biology
  • Regenerative medicine
  • Cellular reprogramming

Background:

  • Forced expression of cardiogenic transcription factors can reprogram fibroblasts into induced cardiomyocyte-like cells (iCMs).
  • This cardiac reprogramming offers a potential strategy for heart regeneration by altering cell fate.
  • The chamber-specific differentiation capacity of reprogrammed cells remains largely unexplored.

Purpose of the Study:

  • To investigate whether cardiac reprogramming can generate chamber-specific cardiomyocytes.
  • To compare the chamber specification of iCMs generated in vitro versus in vivo.

Main Methods:

  • Cardiac reprogramming of fibroblasts using core cardiogenic transcription factors.
  • Assessment of chamber identity in iCMs generated both in vitro and in vivo following myocardial infarction.

Main Results:

  • In vivo cardiac reprogramming post-myocardial infarction exclusively yielded ventricular-like iCMs.
  • A significant proportion of in vitro-generated iCMs failed to achieve specific chamber identities.
  • In vivo reprogramming demonstrated a potential for chamber-matched cardiomyocyte generation.

Conclusions:

  • In vivo cardiac reprogramming exhibits an inherent advantage in generating chamber-specific cardiomyocytes.
  • This approach holds promise as a potential strategy for heart regeneration.
  • Further research into in vivo reprogramming could advance cardiac repair therapies.